ALLOS THERAPEUTICS INC 4
4 · ALLOS THERAPEUTICS INC · Filed Mar 1, 2012
Insider Transaction Report
Form 4
BENNETT BRUCE K JR
VP, Manufacturing
Transactions
- Sale
Common Stock
2012-02-29$1.53/sh−3,031$4,623→ 150,403 total - Sale
Common Stock
2012-03-01$1.50/sh−3,025$4,522→ 147,378 total - Award
Common Stock
2012-02-28+43,862→ 153,434 total
Footnotes (4)
- [F1]Represents shares of common stock issued as restricted stock units ("RSUs") awarded under the Company's 2008 Equity Incentive Plan (the "Plan"). The RSUs shall vest in a series of eight (8) successive equal semi-annual installments over the four (4)-year period measured from March 18, 2012 (the "Vesting Commencement Date"), subject to Participant's Continuous Service through each such date.
- [F2]These shares are being sold pursuant to a 10b5-1 plan for Mr. Bennett under which a portion of his holdings were sold for tax and estate planning purposes in connection with the delivery of shares covered by restricted stock units which vested on February 28, 2012.
- [F3]The price represents the weighted average sale price for multiple transactions reported on this line. The prices of the transactions ranged from $1.52 to $1.54. Upon request of the SEC staff, Allos Therapeutics, Inc. (the "Company") or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold at each separate price.
- [F4]The price represents the weighted average sale price for multiple transactions reported on this line. The prices of the transactions ranged from $1.49 to $1.50. Upon request of the SEC staff, Allos Therapeutics, Inc. (the "Company") or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold at each separate price.